Vineet R. Jindal - 10 Dec 2021 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Reporting relationship: Chief Financial Officer
Issuer ticker: OKUR
Reported as of: 10 Dec 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Dec 2021, 15:32:15 UTC
Prior SEC filing: 26 Aug 2021
Source filing: View source filing
Reporting owner signature: /s/ Vineet R. Jindal

Key filing fact

Vineet R. Jindal filed Form 4 for Reneo Pharmaceuticals, Inc. (OKUR) on 14 Dec 2021.

Key facts

This page summarizes Vineet R. Jindal's Form 4 filing for Reneo Pharmaceuticals, Inc. (OKUR).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Dec 2021, 15:32.

Change

Previous filing in this sequence was filed on 26 Aug 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RPHM transaction

Common Stock

Award

Transaction value: $0
Shares: +30,000
Change %: +455%
Price: $0.000000
Shares after: 36,600
Date: 10 Dec 2021
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RPHM transaction Derivative

Stock option (right to buy)

Award

Transaction value: $0
Shares: +100,000
Change %
Price: $0.000000
Shares after: 100,000
Date: 10 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $6.69
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents a restricted stock unit award.

Footnote F2

Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 8, 2021.

Footnote F3

The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.